Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer

Name: Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
License: Public Domain

Changzhou Cancer Hospital of Soochow University

ClinicalTrials.gov · Datasets · License: Public Domain

small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148762
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.